The follicular lymphoma microenvironment: From tumor cell to host immunity
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Follicular lymphoma (FL) is a neoplasm derived from follicular germinal center cells. Like the normal components of this lymphoid structure, FL cells interact with various immune cells, such as the follicular helper T cells, suppressor regulatory T cells, dendritic cells, and histiocytes, that define the tumor microenvironment. Gene expression studies have shown that the nature of the tumor microenvironment predicts survival in patients with FL and may influence the response to immunotherapy and risk of transformation. The immune system may either promote or constrain tumor cell development, depending on the relative distribution and activation status of various cell subpopulations. The prognostic value of germline genetic variants of some immune genes suggests that the host genetic background may also influence the biology of FL. Some efforts have been carried out to validate those findings and provide clinical tools that may be used at the time of diagnosis.
- de Jong D: Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 2005, 23:6358–6363. CrossRef
- Dave SS, Wright G, Tan B, et al.: Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004, 351:2159–2169. CrossRef
- Glas AM, Kersten MJ, Delahaye LJ, et al.: Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood 2005, 105:301–307. CrossRef
- Glas AM, Knoops L, Delahaye L, et al.: Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 2007, 25:390–398. CrossRef
- Husson H, Carideo EG, Neuberg D, et al.: Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 2002, 99:282–289. CrossRef
- Sato E, Olson SH, Ahn J, et al.: Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 2005, 102:18538–18543. CrossRef
- Galon J, Costes A, Sanchez-Cabo F, et al.: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313:1960–1964. CrossRef
- Rosenberg SA, Restifo NP, Yang JC, et al.: Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008, 8:299–308. CrossRef
- Schultze JL, Seamon MJ, Michalak S, et al.: Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro. Blood 1997, 89:3806–3816.
- Farinha P, Gascoyne RD: Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2005, 23:6370–6378. CrossRef
- Rohatiner AZ, Gregory WM, Peterson B, et al.: Meta-analysis to evaluate the role of interferon in follicular lymphoma. J Clin Oncol 2005, 23:2215–2223. CrossRef
- Farinha P, Masoudi H, Skinnider BF, et al.: Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 2005, 106:2169–2174. CrossRef
- Carreras J, Lopez-Guillermo A, Fox BC, et al.: High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006, 108:2957–2964. CrossRef
- Byers RJ, Sakhinia E, Joseph P, et al.: Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. Blood 2008, 111:4764–4770. CrossRef
- Alvaro T, Lejeune M, Camacho FI, et al.: The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma. Haematologica 2006, 91:1605–1612.
- Jaffe ES, Shevach EM, Frank MM, et al.: Nodular lymphoma—evidence for origin from follicular B lymphocytes. N Engl J Med 1974, 290:813–819.
- Bende RJ, Smit LA, van Noesel CJ: Molecular pathways in follicular lymphoma. Leukemia 2007, 21:18–29. CrossRef
- Klein U, Dela-Favera R: Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008, 8:22–33. CrossRef
- Cong P, Raffeld M, Teruya-Feldstein J, et al.: In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 2002, 99:3376–3382. CrossRef
- Gine E, Montoto S, Bosch F, et al.: The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Ann Oncol 2006, 17:1539–1545. CrossRef
- Bohen SP, Troyanskaya OG, Alter O, et al.: Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci U S A 2003, 100:1926–1930. CrossRef
- Rademakers LH, Peters JP, van Unnik JA: Histiocytic and dendritic reticulum cells in follicular structures of follicular lymphoma and reactive hyperplasia. A quantitative electron microscopical analysis. Virchows Arch B Cell Pathol Incl Mol Pathol 1983, 44:85–98. CrossRef
- Alvaro T, Lejeune M, Salvadó MT, et al.: Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol 2006, 24:5350–5357. CrossRef
- Lee AM, Clear AJ, Calaminici M, et al.: Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 2006, 24:5052–5059. CrossRef
- Banham AH, Powrie FM, Suri-Payer E: FOXP3+ regulatory T cells: current controversies and future perspectives. Eur J Immunol 2006, 36:2832–2836. CrossRef
- Lim HW, Hillsamer P, Kim CH: Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 2004, 114:1640–1649.
- Zhao D-M, Thornton AM, Dipaolo RJ, Shevach EM: Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 2006, 107:3925–3932. CrossRef
- King C, Tangye SG, Mackay CR: T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol 2008, 26:741–766. CrossRef
- Haynes NM, Allen CD, Lesley R, et al.: Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1 high germinal center-associated subpopulation. J Immunol 2007, 179:5099–5108.
- Roncador G, García Verdes-Montenegro JF, Tedoldi S, et al.: Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007, 92:1059–1066. CrossRef
- Canioni D, Salles G, Mounier N, et al.: High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol 2008, 26:440–446. CrossRef
- Mantovani A, Sica A, Locati M: New vistas on macrophage differentiation and activation. Eur J Immunol 2007, 37:14–16. CrossRef
- Shortman K, Liu YJ: Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151–161. CrossRef
- Park CS, Choi YS: How do follicular dendritic cells interact intimately with B cells in the germinal centre? Immunology 2005, 114:2–10. CrossRef
- Chang KC, Huang X, Medeiros LJ, Jones D: Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma. J Pathol 2003, 201:404–412. CrossRef
- Clayberger C, Luna-Fineman S, Lee JE, et al.: Interleukin 3 is a growth factor for human follicular B cell lymphoma. J Exp Med 1992, 175:371–376. CrossRef
- Peuchmaur M, Emilie D, Crevon MC, et al.: Interleukin-2 and interferon-gamma production in follicular lymphomas. Am J Clin Pathol 1991, 95:55–62.
- Fujii A, Oshima K, Hamasaki M, et al.: Differential expression of cytokines, chemokines and their receptors in follicular lymphoma and reactive follicular hyperplasia: assessment by complementary DNA microarray. Oncol Rep 2005, 13:819–824.
- Akamatsu N, Yamada Y, Hasegawa H, et al.: High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma. Cancer Lett 2007, 256:196–206. CrossRef
- Martinez A, Pittaluga S, Rudelius M, et al.: Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker. Am J Surg Pathol 2008, 32:1190–1200. CrossRef
- Karube K, Guo Y, Suzumiya J, et al.: CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood 2007, 109:3076–3079.
- Cerhan JR, Ansell SM, Fredericksen ZS, et al.: Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007, 110:4455–4463. CrossRef
- Nieters A, Beckmann L, Deeg E, Becker N: Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun 2006, 7:615–624. CrossRef
- The follicular lymphoma microenvironment: From tumor cell to host immunity
Current Hematologic Malignancy Reports
Volume 3, Issue 4 , pp 179-186
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links